Cooperation between p53-dependent and p53-independent apoptotic pathways in myeloid cells

Cancer Research

Volumn 56, Issue 9, 1996, Pages 2148-2156

  Peled, Amnon ^a   Zipori, Dov ^a   Rotter, Varda ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; DNA DAMAGE; ENZYME INHIBITION; MITOSIS SPINDLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION;

ANIMALS; APOPTOSIS; BONE MARROW; CELL LINE; G0 PHASE; G1 PHASE; MICE; MUTATION; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; STROMAL CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029935573     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Shaulsky, G , Goldfinger, N., Peled, A., and Rotter, V. Involvement of wild type p53 in pre-B cell differentiation in vitro Proc. Natl. Acad. Sci. USA. 88 8982-8986, 1991.
2. Deppert, W , Buschhausen-Denker, G. Patschinsky, T., and Steinmeyer, K. Cell cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II Requirement for cell cycle progression. Oncogene. 5: 1701-1706, 1990
3. Diller, L , Kassel, J., Nelson, C. E., Gryka, M A , Litwak, G., Gebhardt, M , Bressac, B., Ozturk, M , Baker, S. J., Vogelstein, B., and Friend, S H p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol , 10: 5772-5781, 1990
4. Ginsberg, D , Mechta, F., Yaniv, M., and Oren, M. Wild type p53 can down-regulate the activity of various promoters Proc. Natl. Acad. Sci USA. 88: 9979-9983, 1991
5. Martinez, J , Georgoff, I., Martinez, J., and Levine, A. J. Cellular localization and cell cycle regulation by a temperature sensitive protein. Genes & Dev., 5: 151-159, 1991.
6. Michalovitz, D., Halevy, O. and Oren, M. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell, 62: 671-680, 1990
7. Mercer, W. E., Shields, M. T., Amin, M , Sauve, G. J., Appella, E., Romano, J. W., and Ullrich, S J. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild type p53. Proc. Natl. Acad. Sci. USA, 87. 6166-6170, 1990
8. Shaulsky, G., Ben-Ze'ev, A., and Rotter, V. Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene, 5: 1707-1711, 1990.
9. Hunter, T. Braking the cycle Cell, 75: 839-841, 1993.
10. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E , Kinzler, K. W., and Vogelstein, B WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
11. 1 cyclin-dependent kinases. Cell. 75: 805-816, 1993
12. 2-dependent immunoglobulin K light chain gene expression. EMBO J., 14. 1392-1401, 1995.
13. Stewart, N., Hicks, G G., Paraskevas, F., and Mowat, M. Evidence for a second cell cycle block at G2/M by p53 Oncogene, 10: 109-115, 1994.
14. Cross, S. M , Sanchez, C. A , Morgan, C. A , Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H , and Reid, B. J. A p53-dependent mouse spindle checkpoint. Science (Washington DC), 267: 1353-1356, 1995.
15. Livingstone, L. R , White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 923-935, 1992.
16. Yonish-Rouach, E., Resnitzky, K., Lotem, J. Sachs, L., Kimchi, A., and Oren, M. Wild type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin 6. Nature (Lond.), 352: 345-347, 1991.
17. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line Proc. Natl Acad. Sci. USA, 89: 4495-4499, 1992.
18. Johnson, P., Chung, S., and Benchimol, S. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobulin production and is sensitive to erythropoietin. Mol. Cell. Biol , 13: 1456-1463, 1993.
19. Ryan, J. J., Danish, R. Gottlieb, C. A., and Clarke, M. F. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol. Cell. Biol., 13: 711-719, 1993.
20. Yin, Y. Tainsky, M. A , Bischoff, F. Z., Strong, L. C., and Wahl, G. M Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70: 937-948, 1992
21. 1 arrest. Cell, 76: 1033-1023, 1994.
22. Yonish-Rouach, E., Grunwald, D., Wilder, S., Kimchi, A., May, E., Lawrence, J. J., May, P , and Oren, M p53-mediated cell death: relationship to cell cycle control. Mol. Cell Biol., 13: 1415-1423, 1993.
23. 1 arrest and long-term induction of Cip1 in normal human fibroblasts Genes & Dev. 8: 2540-2551, 1994.
24. Wyllie, A. H. The genetic regulation of apoptosis. Curr. Opin Genet Dev., 5. 97-104, 1995.
25. Williams, G T Programmed cell death: apoptosis and oncogenesis. Cell. 65: 1097-1098, 1991
26. Oltvai, Z. N., and Korsmeyer, S. J Checkpoints of dueling dinners foil death wishes Cell, 79: 189-192, 1994
27. Lowe, S. W., Schmitt, E. M., Smith, S. W , Osborne, B. A , and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-853, 1993.
28. Lowe, S. W , Earl Ruley, H., Jacks. T , and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents Cell, 74: 957-967, 1993.
29. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S. Jacks, T., and Van Dyke. T p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell. 78: 703-711, 1994.
30. Clarke, A R , Purdie, C. A., Harrison, D. J , Morris, R G., Bird, C. C., Hooper, M. L., and Wjllie, A H. Thymocyte apoptosis induced by p53-dependent and independent pathways Nature (Lond.), 362: 849-852, 1993.
31. Clarke, A R , Gledhill, S., Hooper, M. L , Bird, C C., and Wyllie, A. H. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation. Oncogene, 9. 1767-1773, 1994.
32. Strasser, A , Harris, A. W., Jacks, T. and Cory, S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79: 329-339, 1994
33. Lu, X., and Lane. D P Differential induction of transcriptionally active p53 following UV or ionizing irradiation: defects in chromosome instability syndromes? Cell. 75 765-778, 1993
34. Zhuang, S M , Shvarts, A., Ormondt, H. V , Jochemsen, A. J van der Ev, A. J., and Notenborn, M. H M. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res , 55 486-189, 1995
35. Berges, R R , Furuya, Y , Remington, L , English, H F., Jacks, T., and Isaacs, J. T Cell proliferation. DNA repair and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc. Acad. Natl Sci. USA, 90: 8910-8914, 1993.
36. 1 and S phases of the cell cycle without growth arrest or stabilization of wild type P53. Mol. Cell. Biol , 14. 4183-4192, 1994.
37. Merlo, G R., Basolo, F., Fiore, L., Duboc, L., and Hynes, N. E. p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin J. Cell Biol., 128: 1185-1196, 1995.
38. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991
39. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation Proc Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
40. Nelson, W. G., and Kastan, M. B. DNA strand breaks-the DNA template alteration that triggers p53 dependent DNA damage response pathways. Mol. Cell. Biol , 14: 1815-1823, 1994
41. Debbas, M., and White, E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes & Dev., 7: 546-554, 1993.
42. Howes, K. A., Ransom, N., Papermaster, D. S., Lasudry, J. G. H., Albert, D. M., and Windle, J. J. Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes & Dev., 8: 1300-1310, 1994.
43. Lowe, S W., and Ruley, H. E. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes & Dev., 7: 535-545, 1993.
44. Miyashita, T , Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., and Liebermann, D. A. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9: 1799-1805, 1994
45. Yang, E., Zha, J., Jockel, J., Boise, L H., Thompson, C. B , and Korsmeyer, S J. Bad, a heterodimeric partner for Bcl-x1 and Bcl-2, displaces bax and promotes cell death. Cell, 80: 285-291, 1995.
46. Peled, A , Lee, B-C., Toledo, J., Aracil, M., and Zipori, D. Interactions between M1 myeloblasts and bone marrow stromal cells under serum free conditions. I. Growth dependence of the myeloblastic cells on TGFβ and synergistic effect of CSF-1. Exp. Hematol. (NY), in press, 1996.
47. Zipori, D., Toledo, J., and von der Mark, K. Phenotypic heterogeneity among stromal cell lines from mouse bone marrow disclosed in their extracellular matrix composition and interaction with normal and leukemic cells. Blood, 66 447-455, 1985.
48. Zipori, D., Duksin, D., Tamir M , Argaman, A., Toledo, J., and Malik, Z. Cultured mouse marrow cell lines. II. Distinct subtypes differing in morphology, collagen type, myelopoietic factors, and leukemic cell growth modulating activities. J. Cell. Physiol., 122: 81-90, 1985
49. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods, 65: 55-63, 1983.
50. Harlow, E., Crawford, L. V., Pim, D. C , and Williamson, N. M. Monoclonal antibodies specific for simian virus 40 tumor antigen. J. Virol., 39: 861-869, 1981.
51. Belloc, F. Dumain, P., Boisseau, M. R., Jalloustre, C., Reiffers, J., Bernard, P., and Lacombe, F. A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry, 17 59-65, 1994.
52. Darzynkiewicz, Z., Li, X , and Gong, J. Assays of cell viability: discrimination of cell dying by apoptosis Methods Cell Biol., 41: 15-38, 1994
53. Gottlieb, E , Haffner, R., von Ruden, T , Wagner, E. F., and Oren, M. Downregulation of wild type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J., 13: 1368-1374, 1994
54. Darzynkiewicz, Z , Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P , and Traganos, F Features of apoptotic cells measured by flow cytometry. Cytometry, 13. 795-808, 1992.
55. Afanasyev, V. N., Korol, B. A., Matylevich, N. P., Pechatnikov, V A , and Umansky, S. R The use of flow cytometry for the investigation of cell death. Cytometry, 14. 603-609, 1993.
56. Dive, C., Gregory, C D., Phipps, D. J., Evans, D. L., Milner, A. E., and Wyllie, A. H Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta, 1133: 275-285, 1992.
57. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139: 271-279, 1991.
58. Lotem, J., and Sachs, L. Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways. Cell Growth & Differ., 5: 321-327, 1994.
59. Baker, S. J , Markowitz, S., Fearon, E. R., Wilson, J. K. V., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
60. Blandino, G., Scardigli, R., Rizzo, M. G., Crescenzi, M., Soddu, S., and Sacchi, A. Wild-type p53 modulates apoptosis of normal. IL-3 deprived, hematopoietic cells Oncogene, 10: 731-737, 1995.
61. Finlay, C. A., Hinds, P. W., and Levine, A. J. The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57: 1083-1093, 1989
62. Wolf, D., Harris, N., and Rotter, V Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene. Cell, 38: 119, 1984.
63. Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A., Moore, M., Finlay, C., and Levine, A. Gain of function mutations in p53. Nat. Genet., 4: 42-46, 1993.